QSimulate, a portfolio company of Abies Ventures, has raised USD 1 million in a convertible note underwritten by the UTokyo Innovation Platform Co. Ltd., Kyoto University Innovation Capital Co. Ltd.

In conjunction with this financing, QSimulate plans to release QuValent, the world’s first covalent inhibitor design system, and open a Japan office to expand the company’s expansion in Japan.

For more information, click on the link below.

https://prtimes.jp/main/html/rd/p/000000003.000061064.html (Japanese only)